Radiopharm Theranostics Limited
Important Dates
RADIOPHARM THERANOSTICS LTD.'s next confirmed earnings release is scheduled for February 26, 2027.
| Earnings Date | 2/26/2027 |
Share Statistics
As of December 31, 2024, RADIOPHARM THERANOSTICS LTD. has 2.20B shares outstanding.
| Shares Outstanding | 2.20B |
Financial Position
As of December 31, 2024, RADIOPHARM THERANOSTICS LTD. maintains a current ratio of 3.37, meaning it holds 3.4x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 3.37 |
| Quick Ratio | 3.25 |
Financial Efficiency
These figures cover the twelve months ended December 31, 2024.
| Employee Count | 7.00 |
Stock Price Statistics
As of the close on September 11, 2026, RADIOPHARM THERANOSTICS LTD.'s stock has declined approximately 66.68% over the past 52 weeks.
| 52-Week Price Change | -66.68% |
Balance Sheet
USDThese figures are as of December 31, 2024. Total book value stands at 32.93M, with working capital of 19.32M providing operational flexibility.
| Cash & Cash Equivalents | 22.56M |
| Net Debt | -22.56M |
| Equity (Book Value) | 32.93M |
| Book Value Per Share | 0.01 |
| Working Capital | 19.32M |
Stock Splits
RADIOPHARM THERANOSTICS LTD.'s most recent stock split took place on November 2, 2023 with a 17:18 split ratio.
| Last Split Date | 11/2/2023 |
| Split Ratio | 17:18 |